Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.

Biotechnology

Lyndra Therapeutics

Kiera Henderson

Richard Scranton

Lindsay Beaupre

Klas Holmlund, CFA

Anna Legedza

Patrick Boen

Jessica Ballinger

Erik Ryde

Jonathan Raber

Liah Dukaye

Morgan Foster

Nicholas Barner

Roman Lovell

Michelle O'Connor

Samuel Chadwick

Kevin Acreman

Rosemary Kanasty

Colin Gardner

Maureen Chlopik

The Leadership Team at Lyndra Therapeutics is responsible for setting the strategic direction and vision of the company, guiding innovation in oral, ultra-long-acting therapies. This team of experienced leaders collaborates across various functions to drive product development, operational efficiency, and market strategy, ensuring the successful advancement of transformative therapeutic solutions that enhance patient adherence to medication regimens.

Leadership Team

Engineering and Scientific Research

Clinical and Scientific Operations

Leadership Team

About

Team members

Other teams at Lyndra Therapeutics

Engineering and Scientific Research

Clinical and Scientific Operations